Jiayu Wang

Nanjing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Correction to: Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.

Correction to: Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.

Journal: BMC cancer
Published: January 27, 2026

Characteristics of cancer mycobiome in patients with acral melanoma.

Characteristics of cancer mycobiome in patients with acral melanoma.

Journal: Journal for immunotherapy of cancer
Published: June 24, 2025

Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.

Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.

Journal: BMC cancer
Published: June 08, 2025

Blocking CCR1+ macrophages overcomes resistance to immune checkpoint inhibitors in melanoma.

Blocking CCR1+ macrophages overcomes resistance to immune checkpoint inhibitors in melanoma.

Journal: Cell communication and signaling : CCS
Published: January 22, 2025

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade.

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade.

Journal: Cancer immunology, immunotherapy : CII
Published: January 19, 2025

C-Reactive Protein to Lymphocyte Ratio (CLR) and Lactate Dehydrogenase to Albumin Ratio (LAR) as Prognostic Biomarkers in Acral Melanoma: Association With Tertiary Lymphoid Structures and Immune Cell Infiltration.

C-Reactive Protein to Lymphocyte Ratio (CLR) and Lactate Dehydrogenase to Albumin Ratio (LAR) as Prognostic Biomarkers in Acral Melanoma: Association With Tertiary Lymphoid Structures and Immune Cell Infiltration.

Journal: Cancer medicine
Published: December 12, 2024

Tertiary lymphoid structures associated with improved survival and enhanced antitumor immunity in acral melanoma.

Tertiary lymphoid structures associated with improved survival and enhanced antitumor immunity in acral melanoma.

Journal: NPJ precision oncology
Published: September 25, 2024

Socioeconomic status correlates with clinical outcomes in patients with acral melanoma.

Socioeconomic status correlates with clinical outcomes in patients with acral melanoma.

Journal: Frontiers in public health
Published: September 13, 2024

Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma.

Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma.

Journal: Journal for immunotherapy of cancer
Published: March 29, 2024

Acidity-targeting transition-aided universal chimeric antigen receptor T-cell (ATT-CAR-T) therapy for the treatment of solid tumors.

Acidity-targeting transition-aided universal chimeric antigen receptor T-cell (ATT-CAR-T) therapy for the treatment of solid tumors.

Journal: Biomaterials
Published: November 22, 2023

Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.

Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.

Journal: Cancer medicine
Published: November 16, 2023

Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.

Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.

Journal: Journal of translational medicine
Published: November 04, 2022
Showing 1-12 of 12

Last Updated: 09/26/2026